PDS Biotechnology Announces Conference Call and Webcast to Present Second Quarter 2021 Financial Results
FLORHAM PARK, N.J., July 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, will release financial results for the second quarter of 2021 on Thursday, August 12, 2021, before the market opens. Following the release, management will host a conference call to review the company’s financial results and provide a business update.
The conference call is scheduled to begin at 8:00 am ET on Thursday, August 12, 2021. Participants should dial 877-407-3088 (United States) or 201-389-0927 (International) and mention PDS Biotechnology. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at www.pdsbiotech.com.
After the live webcast, the event will be archived on PDS Biotech’s website for 6 months. In addition, a telephonic replay of the call will be available for 6 months. The replay can be accessed by dialing 877-660-6853 (Unted States) or 201-612-7415 (International) with confirmation code 13721612.
About PDS Biotechnology
CONTACT: Media & Investor Relations Contact:
Mistakes VARs Can't Afford to Make in the Cannabis Market
IoT Evolution Expo #TECHSUPERSHOW Expo Hall Open
Keynote Presentation - Open to all Badge Holders